Kiora Pharmaceuticals, Inc.

Historical 13F Holders

Reported Value, Excluding Options

Total Filings

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 49721T101 since 12/18/2024, largest first.

Filer	% of Class	Shares	Form	Filed
Rosalind Advisors, Inc. 13G/A	9.9%	464,676	13G/A	2/11/2026 Event 12/31/2025
Rosalind Advisors, Inc.	9.9%	464,676
Salamon Steven A J	9.9%	464,676
Aharon Gil	9.9%	464,676
Rosalind Master Fund L.P.	9.9%	464,676

Period	Filings	Shares, Excl. Options	Value, Excl. Options	Options Value
2022 Q2	15	836 k	$391 k	$0
2022 Q1	17	831 k	$517 k	$0
2021 Q4	14	805 k	$1.22 M	$0